A study to look at the clinical, human and economic effects on patients who suffer prolonged epileptic seizures
| ISRCTN | ISRCTN71452613 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN71452613 |
| Integrated Research Application System (IRAS) | 370112 |
| Sponsor | UCB |
| Funder | UCB |
- Submission date
- 17/09/2026
- Registration date
- 19/11/2026
- Last edited
- 13/11/2026
- Recruitment status
- Recruiting
- Overall study status
- Ongoing
- Condition category
- Nervous System Diseases
Plain English summary of protocol
Background and study aims
The study is designed to look at patients who suffer from prolonged seizures (PS) in epilepsy. The study will collect information on the clinical effects (medical outcomes), human effects (effects on everyday life) and economic effects (effects on ability to work) in this group of patients.
Who can participate?
Patients aged at least 12 years old who suffer from PS
What does the study involve?
Patients will be asked to complete questionnaires (three times over a 6-month period) and study diaries capturing seizures for 6 months. These will be completed electronically on a phone or tablet.
What are the possible benefits and risks of participating?
There are no benefits from taking part, but the study may collect information which is useful in the treatment of this group of patients in the future.
Where is the study run from?
UCB Biopharma SRL (Belgium)
When is the study starting and how long is it expected to run for?
September 2026 to September 2027
Who is funding the study?
UCB Biopharma SRL (Belgium)
Who is the main contact?
Fiona McNulty, fiona.mcnulty@ubc.com
Contact information
Principal investigator
Institute of Neurosciences, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde
Glasgow
G51 4TF
United Kingdom
| Phone | +44 (0)141 2012374 |
|---|---|
| Craig.Heath2@nhs.scot |
Public, Scientific
23 Spring Meadows
Warrenpoint
BT34 3SU
United Kingdom
| Phone | +44 (0)7740651840 |
|---|---|
| fiona.mcnulty@ubc.com |
Study information
| Primary study design | Observational |
|---|---|
| Observational study design | Prospective observational study |
| Scientific title | The clinical, humanistic and economic patient burden of prolonged seizures in epilepsy: a prospective observational study in the UK (RWE1597) |
| Study acronym | RWE1597 |
| Study objectives | 1. To characterize the population of patients with PS in terms of demographic and clinical characteristics, including diagnostic and medical history, and seizure type(s) 2. To characterize the patient experience of PS events and clinical outcomes over the observation period 3. To describe healthcare resource utilization (HCRU) in patients with PS 4. To assess health-related quality of life (HRQoL) in patients with PS |
| Ethics approval(s) |
Approved 25/08/2026, Proportionate Review Sub-committee of the South West - Central Bristol Research Ethics Committee (2 Redman Place, Stratford, London, E20 1JQ, United Kingdom; -; centralbristol.rec@hra.nhs.uk), ref: 26/SW/0100 |
| Health condition(s) or problem(s) studied | Epilepsy |
| Methodology | Observational study including questionnaires and patient diaries. Patients will receive usual care. Patients will be asked to complete questionnaires (three times over a 6-month period) and study diaries capturing seizures for 6 months. These will be completed electronically on a phone or tablet. |
| Intervention type | Other |
| Primary outcome measure(s) |
|
| Key secondary outcome measure(s) | |
| Completion date | 15/09/2027 |
Eligibility
| Participant type(s) | |
|---|---|
| Age group | Mixed |
| Lower age limit | 12 Years |
| Upper age limit | 100 Years |
| Sex | All |
| Target sample size at registration | 100 |
| Key inclusion criteria | 1. Is at least 12 years old at the time of providing assent/consent for study participation 2. Has a documented medical diagnosis of epilepsy 3. Is at risk of prolonged seizures (PS) according to the REST definitions based on physician’s clinical impression of seizure history and disease status 4. Has had at least one PS event within the last month prior to study enrolment evaluation 5. Patient has sufficient cognitive ability to understand the Patient-Reported Outcome questionnaires and seizure diary items and to provide their own answers. Patients may receive non-directive assistance limited to technical or physical support (e.g., typing or navigating the device), provided that all response content is generated by the patient 6. Informed consent and, where applicable, assent for participation will be obtained in accordance with applicable national regulations and the procedures approved by the Ethics Committee 7. The patient, and caregiver/LAR if applicable, has sufficient command of English language to understand the study information and requirements |
| Key exclusion criteria | 1. Is enrolled in any clinical trial at the time of assent/consent for study participation 2. Has a history of presence of known non-epileptic seizures which cannot be distinguished from qualifying epileptic seizures |
| Date of first enrolment | 09/09/2026 |
| Date of final enrolment | 09/03/2027 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centres
Wolverhampton Road
Heath Town
Wolverhampton
WV10 0QP
England
Freeman Road
High Heaton
Newcastle upon Tyne
NE7 7DN
England
Herries Road
Sheffield
S5 7AU
England
London
NW1 2PG
England
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|
Editorial Notes
30/09/2026: Study's existence confirmed by the Proportionate Review Sub-committee of the South West - Central Bristol Research Ethics Committee.